Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-04-06
2000-01-25
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 435375, 435377, 536 241, 536 245, A61K 4800, C07H 2104
Patent
active
060178981
ABSTRACT:
Oligonucleotides are provided which are effective in inhibiting the growth, metastasis and/or angiogenesis of tumors, including particularly melanoma and/or lung cancer. Methods are also provided for use of these oligonucleotides in the treatment of diseases.
REFERENCES:
Branch "A Good Antisense Molecule is Hard to Find" TIBS vol. 23: 45-50, 1998.
Agrawal "Antisense Oligonucleotides: Towards Clinical Trials." TIBTECH vol. 14: 376-387, 1996.
Cieslak Dariusz
Olbina Gordana
Pietrzkowski Zbigniew
Elliott George C.
Fish Robert D.
ICN Pharmaceuticals, Inc.
McGarry Sean R.
LandOfFree
Inhibition of tumor growth by antisense oligonucleotides for IL- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of tumor growth by antisense oligonucleotides for IL-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of tumor growth by antisense oligonucleotides for IL- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316025